Related Experiment Video
Updated: Aug 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Treatment in diffuse interstitial lung diseases]
1Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey. kayacan@medicine.ankara.edu.tr
Abstract:
Diffuse interstitial lung diseases are parenchymal diseases of the lung with many various etiologies and most of which are idiopathic. The mainstays of the treatment are corticosteroids and immunosuppressants. This paper deals with the treatment of idiopathic interstitial pneumonias and sarcoidosis.
Related Concept Videos
Other Pulmonary Disorders
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: